D.E. Shaw & Co’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

D.E. Shaw & Co’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-601,135	Closed	-$6.1M	–	5344
2022 Q3	$6.1M	Hold	601,135	–	–	0.01%	1864
2022 Q2	$6.03M	Buy	601,135 +25,003	+4%	+$251K	0.01%	1908
2022 Q1	$5.77M	Buy	576,132 +309,466	+116%	+$3.1M	0.01%	2150
2021 Q4	$2.65M	Buy	+266,666	New	+$2.64M	﹤0.01%	3092

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

D.E. Shaw & Co's ARCK Position: Q4 2022 in Review

D.E. Shaw & Co sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 601,135 shares — an estimated $6.1M sold.

D.E. Shaw & Co first reported a position in ARCK in Q4 2021 and held it in 4 quarters. The position peaked at $6.1M in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

D.E. Shaw & Co reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
D.E. Shaw & Co sold 601,135 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $6.1M.
D.E. Shaw & Co first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q4 2021 and held it in 4 quarters.
D.E. Shaw & Co's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $6.1M in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.